Arce-Gallego et al; Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer. DOI: 10.1038/s41698-025-01179-y

Published: 20 November 2025| Version 1 | DOI: 10.17632/yc7tvmmr73.1
Contributors:
Sara Arce-Gallego, Joaquin Mateo

Description

Data from publication DOI: 10.1038/s41698-025-01179-y Targeted NGS (DNA) and RNAseq data (expression levels and DGEA) included in this manuscript

Files

Institutions

  • Vall d'Hebron Institut d'Oncologia

Categories

Prostate Cancer

Licence